In the pharmaceutical market, numerous key players, including multinational corporations, biotechnology firms, and generic drug manufacturers, actively shape the industry landscape. Entities such as Pfizer, Novo Nordisk, and Vertex Pharmaceuticals Incorporated, engage in extensive research and development endeavors to introduce novel medications and therapies, often targeting prevalent diseases and medical conditions.
Now, you might be asking, why do I need to learn more about these companies? To answer that, we have to turn to analysts who determine the favorability of a company by studying its performance in the past and future projections provided by the company’s investments and roadmap. For instance, the pipeline is a crucial variable that helps determine where the company is headed. Thoughts?
good point. the pipeline gives us an idea about where the company is investing its resources currently, whereas, the track record is crucial in determining its favorability.
holding my breath for updates on amycretin. after ozempic's rise, this might be their next golden ticket